Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	52	non-cytoplasmic
53	76	transmembrane
77	85	cytoplasmic
86	105	transmembrane
106	110	non-cytoplasmic
111	132	transmembrane
133	144	cytoplasmic
145	167	transmembrane
168	186	non-cytoplasmic
187	206	transmembrane
207	264	cytoplasmic
265	288	transmembrane
289	302	non-cytoplasmic
303	324	transmembrane
325	331	cytoplasmic
332	352	transmembrane
353	371	non-cytoplasmic
372	395	transmembrane
396	406	cytoplasmic
407	426	transmembrane
427	435	non-cytoplasmic
436	457	transmembrane
458	469	cytoplasmic

Input:
>WP_027721048.1 NCBI__GCF_000425265.1:WP_027721048.1
MISAPTSDKQPACIAFVLLLSTAAALGGFLFGFDTAVINGAVIALGDYFKVGPVLVGMSV
SLALLGSAVGALGSGYISDKYGRIKGMMLAAVLFTASGVGAGLPFTVWDFIFWRILGGIG
IGLASAITPAYIAEISPASLRGRFGSLQQLAIVVGIFIAMLSNYMLVEVAGGSAGNELWF
GFETWRWMFWAEVPPALLYLIASMMIPESPRYLIGRGRETEAHEILGKVIGDSVLEKIEE
IKVTLQVEGGAAFADIKGRIGFKHIVWLGLGLSVLQQFVGINVIFYYGSMLWRSVGFTEQ
HSLWITVVTGIVNIVTTLIAIVFIDCIGRKPLLLSGSAGMVITLGILAYLFGTAPLDAAG
NPKLIGETATTALVAANIYVFCFGFSWGPVVWVLLGEMFNNRMRASALALGAGAQWVANF
VVSASFPSLVEWVGLGFTYLGYTFFAAVSFFFVMFLIRETRGRELEDME

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server